Trump-Linked Group Challenges Organ Transplant Regulations

Aide Stephen Miller, associated with Trump, is urging major federal health agencies to revoke regulations from the Biden era. He argues these guidelines favor organ transplant decisions based on race rather than medical need.

Initially proposed by the Department of Health and Human Services (HHS) and the Centers for Medicare and Medicaid Services (CMS), the regulations included a portion regarding capital performance adjustments. However, that segment was removed before the rules were finalized.

The Increasing Organ Transplant Access (IOTA) model evaluates participating hospitals on three key metrics for kidney transplants: achievement, efficiency, and quality. Depending on their performance, hospitals may earn funding, owe payments back to the government, or neither.

Interestingly, the health equity challenges were woven into a “voluntary” plan that hospitals were encouraged to adopt, rather than through direct score adjustments. This plan urges hospitals to pinpoint “health disparities” and set “equity goals” to track their progress, using specific metrics to gauge success in addressing targeted health issues.

A press release from the America First Legal (AFL) group stated, “Federal rules cannot induce or normalize discrimination, even in the name of improving ‘fairness.’” They highlighted that CMS made the health equity plan “voluntary,” yet it was integrated into a mandatory federal structure that encourages race-based considerations in transplant decisions.

The IOTA program, lasting six years, builds on previous payment models that gauged whether financial incentives could enhance care and widen access for Medicare and Medicaid patients. The rule was published in the Federal Register on December 4 and took effect on July 1.

As of now, 67 out of 103 hospitals involved in the IOTA model are reportedly committed to diversity, equity, and inclusion (DEI) initiatives, which critics argue promotes “identity-based preferences” in organ transplants.

AFL attorney Megan Redshaw stated, “The IOTA model reflects questionable capital policies that lead hospitals to see life-saving care through a DEI perspective.” She stressed that organ allocation must be based on established medical guidelines, not racial or identity factors, cautioning against adding race-focused pressures to a system already struggling with ethical challenges.

Shortly after taking office, President Biden issued Executive Order 13985, mandating federal agencies to assess whether “underserved communities” encounter systemic barriers in accessing federal programs. This directive also commanded agencies to formulate plans to address these obstacles.

In line with this, CMS sought public feedback in December 2021 on strategies to “promote equity and reduce disparities in organ transplants.” The agency noted that Black Americans are significantly more likely to develop kidney failure compared to their white counterparts, while Latinos also face higher risks. Yet, data indicates that these groups have less access to transplants despite needing them.

Critics, including Trump administration allies, question the external influences on the drafting of the IOTA model and have pursued legal inquiries to investigate the Biden administration’s alleged push for DEI in organ transplants.

The AFL highlighted a recent initiative from the Biden administration aimed at modernizing the organ transplant system with a focus on enhancing equity and performance. Furthermore, there were changes made to how racial and ethnic information about organ donors was presented in various data reports used by the Organ Procurement and Transplant Network (OPTN).

Concerns have also been raised regarding the premature start of organ harvests during patient recovery, prompting HHS to commit to reforms in the OPTN after discovering troubling practices by key organ procurement organizations.

The AFL claims the IOTA model breaches several legal frameworks, including Title VI of the Civil Rights Act and the Equal Protection Clause. They also argue that it oversteps CMS’ authority under the Social Security Act and is inconsistent with the Administrative Procedures Act.

“The Biden administration built this kidney transplant policy on the incorrect idea that equity requires discrimination,” Redshaw noted. “This approach replaces medical judgment with race-based criteria, risking the lives of those on waiting lists for reasons unrelated to clinical needs. Every American deserves equal treatment under the law, especially in life-and-death situations.”

As of now, HHS and CMS have yet to respond to requests for commentary regarding these claims.